Advisors Asset Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Advisors Asset Management’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3,315	Closed	-$82K	–	1643
2019 Q1	$82K	Sell	3,315 -1,128	-25%	-$28.3K	﹤0.01%	1555
2018 Q4	$80K	Sell	4,443 -139	-3%	-$2.84K	﹤0.01%	1368
2018 Q3	$135K	Sell	4,582 -215	-4%	-$8.32K	﹤0.01%	1298
2018 Q2	$218K	Sell	4,797 -274	-5%	-$13.3K	﹤0.01%	1236
2018 Q1	$294K	Sell	5,071 -69	-1%	-$4.03K	﹤0.01%	1168
2017 Q4	$350K	Sell	5,140 -89	-2%	-$6.22K	0.01%	1145
2017 Q3	$431K	Buy	5,229 +3,334	+176%	+$264K	0.01%	1103
2017 Q2	$177K	Buy	1,895 +1,168	+161%	+$71.5K	﹤0.01%	1288
2017 Q1	$46K	Buy	+727	New	+$44.2K	﹤0.01%	1451

Other funds holding CLVS

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Advisors Asset Management's CLVS Position: Q2 2019 in Review

Advisors Asset Management sold out of Clovis Oncology, Inc. (CLVS) in Q2 2019, closing a stake of 3,315 shares — an estimated $82K sold.

Advisors Asset Management first reported a position in CLVS in Q1 2017 and held it in 9 quarters. The position peaked at $431K in Q3 2017. 167 funds tracked by Wall St. Rank hold CLVS as of Q2 2019.

Advisors Asset Management reported no remaining Clovis Oncology, Inc. position as of Q2 2019 after selling out during the quarter.
Advisors Asset Management sold 3,315 Clovis Oncology, Inc. shares in Q2 2019, an estimated $82K.
Advisors Asset Management first reported a position in Clovis Oncology, Inc. in Q1 2017 and held it in 9 quarters.
Advisors Asset Management's Clovis Oncology, Inc. position peaked at $431K in Q3 2017.
167 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2019.

Based on Advisors Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.